COMPOUND PROFILE / SMALL MOLECULES
Capromorelin.
Research draftCapromorelin is a small-molecule ghrelin-receptor agonist.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
Capromorelin is a small-molecule ghrelin-receptor agonist.
Mechanism
It influences appetite and growth-hormone-related signalling.
Human research
Human pharmacology studies exist, but they do not establish an approved human enhancement use.
Preclinical & other research
Preclinical and veterinary work must remain separate from human outcomes.
Safety & unknowns
Endocrine and glucose effects require attention; animal dosing cannot determine human safety.
Regulatory status
Veterinary authorisation does not establish human medicine approval.
Reported use & evidence
The supplied Capromorelin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.